About MedChem Express (MCE)
Founded in 2006, MedChemExpress (MCE) develops research reagents and screening tools for drug discovery and life science research. The company specialises in bioactive small molecules, including inhibitors, agonists, natural products, PROTACs, molecular glues and reference standards. Its portfolio also includes recombinant proteins, antibodies and biological reagents. These products support target validation, pathway analysis and mechanism-of-action studies across oncology, immunology, infectious disease, neuroscience, metabolism and cardiovascular research.
MCE offers bioactive compounds, screening libraries, recombinant proteins, antibodies, oligonucleotides, assay kits, cell culture reagents and antibody-drug conjugate (ADC) research products. The portfolio supports workflows including phenotypic screening, cell biology, immunology studies, biomarker research and therapeutic development. The company also provides drug screening, virtual screening, lead optimisation, custom synthesis and analytical services for preclinical research programmes.
Europa Biosite distributes for MCE in Belgium, Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Sweden, Switzerland and the United Kingdom.